Literature DB >> 14602136

Cytokine-regulated expression of collagenase-2 (MMP-8) is involved in the progression of ovarian cancer.

S Stadlmann1, J Pollheimer, P L Moser, A Raggi, A Amberger, R Margreiter, F A Offner, G Mikuz, S Dirnhofer, H Moch.   

Abstract

Matrix metalloproteinases (MMPs) have been implicated in ovarian cancer progression. Among them, MMP-8 that degrades type I collagen may play a crucial role. The aim of our study was to determine MMP-8 expression and regulation in ovarian cancer and its association with other MMPs and tissue inhibitors of metalloproteinases (TIMPs). Tissue microarrays (TMAs) containing tissue cylinders from 302 patients were used for immunohistochemical studies. In addition, MMP-8 expression in vitro was analysed by a specific immunoassay and PCR-analysis. MMP-7 (81%), MMP-8 (95%), MT3-MMP (100%), TIMP-2 (100%), and TIMP-3 (96%) were expressed in all the OVCAs, but the staining intensities varied. MMP-3 (6%), MMP-9 (57%) and TIMP-1 (43%) expressions were more rarely detected. Only MMP-8 expression levels correlated with tumour grade (P<0.01), tumour stage (P<0.01), and a poor prognosis (P<0.05). MMP-8 protein and gene expression in vitro was found to be significantly upregulated by interleukin-1beta (IL-1beta, P<0.01). The data indicate that MMP-8 overexpression in OVCAs is regulated by IL-1beta and that pro-inflammatory cytokines may promote the invasive potential of ovarian cancer.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14602136     DOI: 10.1016/j.ejca.2003.08.011

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  32 in total

Review 1.  Matrix-metalloproteinases as targets for controlled delivery in cancer: An analysis of upregulation and expression.

Authors:  Kyle J Isaacson; M Martin Jensen; Nithya B Subrahmanyam; Hamidreza Ghandehari
Journal:  J Control Release       Date:  2017-01-31       Impact factor: 9.776

2.  Combined structure- and ligand-based pharmacophore modeling and molecular dynamics simulation studies to identify selective inhibitors of MMP-8.

Authors:  Sukesh Kalva; D Vinod; Lilly M Saleena
Journal:  J Mol Model       Date:  2014-04-23       Impact factor: 1.810

3.  Genetic variants in matrix metalloproteinase genes as disposition factors for ovarian cancer risk, survival, and clinical outcome.

Authors:  Yan Wang; Yuanqing Ye; Jie Lin; Larissa Meyer; Xifeng Wu; Karen Lu; Dong Liang
Journal:  Mol Carcinog       Date:  2013-11-19       Impact factor: 4.784

Review 4.  Ovarian cancer: involvement of the matrix metalloproteinases.

Authors:  Linah Al-Alem; Thomas E Curry
Journal:  Reproduction       Date:  2015-04-27       Impact factor: 3.906

5.  Matrix metalloproteinase 3 is a stromal marker for chicken ovarian cancer.

Authors:  Jin Won Choi; Suzie E Ahn; Deivendran Rengaraj; Hee Won Seo; Whasun Lim; Gwonhwa Song; Jae Yong Han
Journal:  Oncol Lett       Date:  2011-08-19       Impact factor: 2.967

6.  CCL25-CCR9 interaction modulates ovarian cancer cell migration, metalloproteinase expression, and invasion.

Authors:  Erica L Johnson; Rajesh Singh; Shailesh Singh; Crystal M Johnson-Holiday; William E Grizzle; Edward E Partridge; James W Lillard
Journal:  World J Surg Oncol       Date:  2010-07-22       Impact factor: 2.754

7.  Clinical utility of circulating matrix metalloproteinase-7 (MMP-7), CC chemokine ligand 18 (CCL18) and CC chemokine ligand 11 (CCL11) as markers for diagnosis of epithelial ovarian cancer.

Authors:  Samir F Zohny; Salah T Fayed
Journal:  Med Oncol       Date:  2009-11-24       Impact factor: 3.064

8.  Matrix metalloproteinase-8 promoter gene polymorphisms in Mexican women with ovarian cancer.

Authors:  Fabian Arechavaleta-Velasco; Rocio Cuevas-Antonio; Pablo Dominguez-Lopez; Isaias Estrada-Moscoso; Fazlollah Shahram Imani-Razavi; Moises Zeferino-Toquero; Laura Diaz-Cueto
Journal:  Med Oncol       Date:  2014-07-18       Impact factor: 3.064

9.  Tissue transglutaminase regulates matrix metalloproteinase-2 in ovarian cancer by modulating cAMP-response element-binding protein activity.

Authors:  Minati Satpathy; Minghai Shao; Robert Emerson; David B Donner; Daniela Matei
Journal:  J Biol Chem       Date:  2009-03-26       Impact factor: 5.157

Review 10.  Role of microRNA-mediated MMP regulation in the treatment and diagnosis of malignant tumors.

Authors:  Liqin Li; Heng Li
Journal:  Cancer Biol Ther       Date:  2013-08-05       Impact factor: 4.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.